|Author||Research Grant||Speakers Bureau/Honoraria||Stock Ownership||Consultant/AdvisoryBoard|
|Dr Kim A. Eagle||Aventis, Biosite, Blue Cross/Blue Shield, Cardiac Science, Mardigian Foundation, Pfizer, University of Michigan, Varbedian Fund for Aortic Research, Walter & Esther Hewlett Foundation||None||None||National Heart, Lung, & Blood Institute; Sanofi-Synthelabo|
|Dr Harlan M. Krumholz||None||None||None||CV Therapeutics|
|Kristi R. Mitchell||None||None||None||None|
|Dr Sharon-Lise T. Normand||Harvard Medical School interfaculty/Merck grant||None||None||Institute for Clinical Evaluative Sciences|
|Dr John A. Spertus||CV Therapeutics||None||None||Amgen, CV Therapeutics, Orqis Medical, Otsuka, World Heart Federation|
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group were required to complete and submit.